Target- |
MechanismImmunomodulators |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Pathogenics, Inc.
0 Patents (Medical) associated with Pathogenics, Inc.
100 Deals associated with Pathogenics, Inc.
100 Translational Medicine associated with Pathogenics, Inc.